|
Volumn 17, Issue 2, 1998, Pages 150-157
|
Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
CYCLOSPORIN A;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MONOCLONAL ANTIBODY;
OLIVE OIL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAPERITONEAL DRUG ADMINISTRATION;
MALE;
NEPHROTOXICITY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
XENOTRANSPLANTATION;
ABDOMEN;
ANIMALS;
ANTIBODIES, MONOCLONAL;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOSUPPRESSIVE AGENTS;
INTERCELLULAR ADHESION MOLECULE-1;
MALE;
RATS;
RATS, SPRAGUE-DAWLEY;
T-LYMPHOCYTES;
TRANSPLANTATION, HETEROTOPIC;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0031914715
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (25)
|